Globus Medical Research and Development Expenses 2010-2023 | GMED
Globus Medical annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Globus Medical research and development expenses for the quarter ending December 31, 2023 were $0.052B, a 167.86% increase year-over-year.
- Globus Medical research and development expenses for the twelve months ending December 31, 2023 were $0.124B, a 69.84% increase year-over-year.
- Globus Medical annual research and development expenses for 2023 were $0.124B, a 69.84% increase from 2022.
- Globus Medical annual research and development expenses for 2022 were $0.073B, a 24.99% decline from 2021.
- Globus Medical annual research and development expenses for 2021 were $0.097B, a 15.18% increase from 2020.
| Globus Medical Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $124 |
| 2022 | $73 |
| 2021 | $97 |
| 2020 | $85 |
| 2019 | $60 |
| 2018 | $55 |
| 2017 | $44 |
| 2016 | $45 |
| 2015 | $36 |
| 2014 | $31 |
| 2013 | $27 |
| 2012 | $28 |
| 2011 | $23 |
| 2010 | $21 |
| 2009 | $21 |
| Globus Medical Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $52 |
| 2023-09-30 | $29 |
| 2023-06-30 | $21 |
| 2023-03-31 | $21 |
| 2022-12-31 | $20 |
| 2022-09-30 | $19 |
| 2022-06-30 | $17 |
| 2022-03-31 | $17 |
| 2021-12-31 | $51 |
| 2021-09-30 | $16 |
| 2021-06-30 | $16 |
| 2021-03-31 | $15 |
| 2020-12-31 | $15 |
| 2020-09-30 | $14 |
| 2020-06-30 | $39 |
| 2020-03-31 | $15 |
| 2019-12-31 | $15 |
| 2019-09-30 | $15 |
| 2019-06-30 | $16 |
| 2019-03-31 | $14 |
| 2018-12-31 | $14 |
| 2018-09-30 | $16 |
| 2018-06-30 | $14 |
| 2018-03-31 | $13 |
| 2017-12-31 | $11 |
| 2017-09-30 | $11 |
| 2017-06-30 | $11 |
| 2017-03-31 | $11 |
| 2016-12-31 | $14 |
| 2016-09-30 | $10 |
| 2016-06-30 | $11 |
| 2016-03-31 | $10 |
| 2015-12-31 | $9 |
| 2015-09-30 | $9 |
| 2015-06-30 | $9 |
| 2015-03-31 | $9 |
| 2014-12-31 | $8 |
| 2014-09-30 | $8 |
| 2014-06-30 | $8 |
| 2014-03-31 | $7 |
| 2013-12-31 | $6 |
| 2013-09-30 | $7 |
| 2013-06-30 | $7 |
| 2013-03-31 | $7 |
| 2012-12-31 | $7 |
| 2012-09-30 | $7 |
| 2012-06-30 | $7 |
| 2012-03-31 | $7 |
| 2011-12-31 | $6 |
| 2011-09-30 | $6 |
| 2011-06-30 | $6 |
| 2011-03-31 | $6 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.953B | $1.568B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.674B | 26.50 |
| Intuitive Surgical (ISRG) | United States | $137.856B | 83.04 |
| DexCom (DXCM) | United States | $51.739B | 78.37 |
| Edwards Lifesciences (EW) | United States | $51.727B | 33.66 |
| IQVIA Holdings (IQV) | United States | $41.749B | 24.22 |
| IDEXX Laboratories (IDXX) | United States | $39.946B | 46.82 |
| Alcon (ALC) | Switzerland | $39.926B | 29.44 |
| STERIS (STE) | Ireland | $21.035B | 24.90 |
| Waters (WAT) | United States | $19.339B | 28.43 |
| Hologic (HOLX) | United States | $17.760B | 19.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.524B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.408B | 77.22 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.801B | 13.77 |
| Sysmex ADR (SSMXY) | Japan | $10.825B | 33.95 |
| Teleflex (TFX) | United States | $9.492B | 14.77 |
| Penumbra (PEN) | United States | $8.139B | 92.51 |
| Masimo (MASI) | United States | $7.196B | 41.59 |
| Glaukos (GKOS) | United States | $5.439B | 0.00 |
| TransMedics (TMDX) | United States | $4.192B | 397.75 |
| Integer Holdings (ITGR) | United States | $3.791B | 22.90 |
| LivaNova (LIVN) | United Kingdom | $3.418B | 20.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.229B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.842B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.783B | 19.09 |
| Inari Medical (NARI) | United States | $2.489B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.426B | 20.52 |
| RxSight (RXST) | United States | $2.300B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.976B | 8.62 |
| Alphatec Holdings (ATEC) | United States | $1.899B | 0.00 |
| Veracyte (VCYT) | United States | $1.608B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 95.08 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.897B | 17.45 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.825B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.811B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.621B | 21.09 |
| IRadimed (IRMD) | United States | $0.553B | 30.99 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.520B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.509B | 0.00 |
| Nevro (NVRO) | United States | $0.423B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 11.74 |
| Sight Sciences (SGHT) | United States | $0.281B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.246B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.213B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.198B | 10.09 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.175B | 0.00 |
| Accuray (ARAY) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.065B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 126.00 |
| Yubo Biotech (YBGJ) | China | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| DarioHealth (DRIO) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |